Skip to main content

GA Gerhardt

First name:
GA
Last name:
Gerhardt
Stenslik, M., Potts, L., Sonne, J., Cass, W., Turchan-Cholewo, J., Pomerleau, F., … Bradley, L. (2015). Methodology and effects of repeated intranasal delivery of DNSP-11 in a rat model of Parkinson’s disease. Journal of Neuroscience Methods, 251, 120-9. https://doi.org/10.1016/j.jneumeth.2015.05.006 (Original work published 2015)
Fuqua, J., Littrell, O., Lundblad, M., Turchan-Cholewo, J., Abdelmoti, L., Galperin, E., … Gerhardt, G. (2014). Dynamic changes in dopamine neuron function after DNSP-11 treatment: effects in vivo and increased ERK 1/2 phosphorylation in vitro. Peptides, 54, 1-8. https://doi.org/10.1016/j.peptides.2013.12.007
Littrell, O., Fuqua, J., Richardson, A., Turchan-Cholewo, J., Hascup, E., Huettl, P., … Gerhardt, G. (2013). A synthetic five amino acid propeptide increases dopamine neuron differentiation and neurochemical function. Neuropeptides, 47(1), 43-9. https://doi.org/10.1016/j.npep.2012.08.004
Kelps, K., Turchan-Cholewo, J., Hascup, E., Taylor, T., Gash, D., Gerhardt, G., & Bradley, L. (2011). Evaluation of the physical and in vitro protective activity of three synthetic peptides derived from the pro- and mature GDNF sequence. Neuropeptides, 45(3), 213-8. https://doi.org/10.1016/j.npep.2011.03.003
Bradley, L., Fuqua, J., Richardson, A., Turchan-Cholewo, J., Ai, Y., Kelps, K., … Gerhardt, G. (2010). Dopamine neuron stimulating actions of a GDNF propeptide. PloS One, 5(3), e9752. https://doi.org/10.1371/journal.pone.0009752 (Original work published 2010)
Stenslik, M., Evans, A., Pomerleau, F., Weeks, R., Huettl, P., Foreman, E., … Bradley, L. (2018). Methodology and effects of repeated intranasal delivery of DNSP-11 in awake Rhesus macaques. Journal of Neuroscience Methods, 303, 30-40. https://doi.org/10.1016/j.jneumeth.2018.03.006 (Original work published 2018)
Grondin, R., Littrell, O., Zhang, Z., Ai, Y., Huettl, P., Pomerleau, F., … Gerhardt, G. (2019). GDNF revisited: A novel mammalian cell-derived variant form of GDNF increases dopamine turnover and improves brain biodistribution. Neuropharmacology, 147, 28-36. https://doi.org/10.1016/j.neuropharm.2018.05.014 (Original work published 2019)
Sompol, P., Furman, J., Pleiss, M., Kraner, S., Artiushin, I., , … Norris, C. (2017). Calcineurin/NFAT Signaling in Activated Astrocytes Drives Network Hyperexcitability in Aβ-Bearing Mice. The Journal of Neuroscience : The Official Journal of the Society for Neuroscience, 37(25), 6132-6148. https://doi.org/10.1523/JNEUROSCI.0877-17.2017 (Original work published 2017)
Thomas, T., Beitchman, J., Pomerleau, F., Noel, T., Jungsuwadee, P., Butterfield, D., … Gerhardt, G. (2017). Acute treatment with doxorubicin affects glutamate neurotransmission in the mouse frontal cortex and hippocampus. Brain Research, 1672, 10-17. https://doi.org/10.1016/j.brainres.2017.07.003 (Original work published 2017)
Gash, D., Gerhardt, G., Bradley, L., Wagner, R., & Slevin, J. (2020). GDNF clinical trials for Parkinson’s disease: a critical human dimension. Cell and Tissue Research, 382(1), 65-70. https://doi.org/10.1007/s00441-020-03269-8